Literature DB >> 17614170

A comparative study of the mutagenicity of various types of tobacco products.

W S Rickert1, W G Wright, A H Trivedi, R A Momin, J H Lauterbach.   

Abstract

Toxicological data are an important aspect of tobacco product characterization. In this study, TPM (Total Particulate Matter) (three replicates) was collected from cigarettes [five brands, ISO conditions: puff volume, 35 mL; duration, 2s; interval, 60s (35/2/60)], cigars (two brands, 45/2/30), cigarillos (two brands, 35/2/60), bidis (two brands, 45/2/30), and pipe tobacco (two brands, 50/2/12). TPM was extracted from the Cambridge filter pad using dimethyl sulfoxide (DMSO). Smokeless tobacco (ST) (six brands) was extracted with DMSO using an ultrasonic homogenizer. Both types of extracts were filtered and stored at -80 degrees C. All extracts were analyzed for humectants, water and nicotine. Mutagenic activity was assessed per OECD guideline 471 using Salmonella typhimurium TA98+S9 and TA100+S9. TA98+S9 response (specific activity expressed as revertants/mg nicotine) was greatest for the cigarette fabricated with dark, air-cured tobaccos. Average product responses with TA98+S9 based on nicotine and relative to cigarettes (excluding dark tobacco) were cigars, 242%; cigarillos, 238%; bidis, 91%; and pipe tobacco, 44%. ST response was not significant for TA98+S9. Corresponding values for TA100+S9 were cigars, 189%; cigarillos, 155%; pipe tobacco, 130%; bidis, 114% and ST, 34%. ST TA100+S9 response ranged from a low of 501 to a high of 8547 revertants/mg nicotine, depending on ST composition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614170     DOI: 10.1016/j.yrtph.2007.05.003

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  11 in total

Review 1.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 2.  Scientific assessment of the use of sugars as cigarette tobacco ingredients: a review of published and other publicly available studies.

Authors:  Ewald Roemer; Matthias K Schorp; Jean-Jacques Piadé; Jeffrey I Seeman; Donald E Leyden; Hans-Juergen Haussmann
Journal:  Crit Rev Toxicol       Date:  2012-01-21       Impact factor: 5.635

Review 3.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

Review 4.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 5.  The in vitro toxicology of Swedish snus.

Authors:  Christopher R E Coggins; Mark Ballantyne; Margareta Curvall; Lars-Erik Rutqvist
Journal:  Crit Rev Toxicol       Date:  2012-03-09       Impact factor: 5.635

6.  Sidestream cigarette smoke effects on cardiovascular responses in conscious rats: involvement of oxidative stress in the fourth cerebral ventricle.

Authors:  Vitor E Valenti; Luiz Carlos de Abreu; Monica A Sato; Celso Ferreira; Fernando Adami; Fernando L A Fonseca; Valdelias Xavier; Moacir Godoy; Carlos B Monteiro; Luiz Carlos M Vanderlei; Paulo H N Saldiva
Journal:  BMC Cardiovasc Disord       Date:  2012-03-30       Impact factor: 2.298

7.  Genetic toxicology and toxicogenomic analysis of three cigarette smoke condensates in vitro reveals few differences among full-flavor, blonde, and light products.

Authors:  Carole L Yauk; Andrew Williams; Julie K Buick; Guosheng Chen; Rebecca M Maertens; Sabina Halappanavar; Paul A White
Journal:  Environ Mol Mutagen       Date:  2012-03-19       Impact factor: 3.216

8.  Brand Cigarillos: Low Price but High Particulate Matter Levels-Is Their Favorable Taxation in the European Union Justified?

Authors:  Julia Wasel; Michael Boll; Michaela Schulze; Daniel Mueller; Matthias Bundschuh; David A Groneberg; Alexander Gerber
Journal:  Int J Environ Res Public Health       Date:  2015-08-06       Impact factor: 3.390

9.  Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols.

Authors:  Manoj Misra; Robert D Leverette; Bethany T Cooper; Melanee B Bennett; Steven E Brown
Journal:  Int J Environ Res Public Health       Date:  2014-10-30       Impact factor: 3.390

10.  Effects of the administration of a catalase inhibitor into the fourth cerebral ventricle on cardiovascular responses in spontaneously hypertensive rats exposed to sidestream cigarette smoke.

Authors:  Vitor E Valenti; Luiz Carlos de Abreu; Fernando L A Fonseca; Fernando Adami; Monica A Sato; Luiz Carlos M Vanderlei; Lucas Lima Ferreira; Luciano M Rodrigues; Celso Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.